Exelixis (EXEL) Reiterated at Market Outperform by Citizens on Positive Q2 Script Growth
Tweet Send to a Friend
Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $55.00 price target on Exelixis (NASDAQ: EXEL).The analyst commented, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
